Upregulation of Nox4 by Hypertrophic Stimuli Promotes Apoptosis and Mitochondrial Dysfunction in Cardiac Myocytes

Rationale: NADPH oxidases are a major source of superoxide (O2−) in the cardiovascular system. The function of Nox4, a member of the Nox family of NADPH oxidases, in the heart is poorly understood. Objective: The goal of this study was to elucidate the role of Nox4 in mediating oxidative stress and growth/death in the heart. Methods and Results: Expression of Nox4 in the heart was increased in response to hypertrophic stimuli and aging. Neither transgenic mice with cardiac specific overexpression of Nox4 (Tg-Nox4) nor those with catalytically inactive Nox4 (Tg-Nox4-P437H) showed an obvious baseline cardiac phenotype at young ages. Tg-Nox4 gradually displayed decreased left ventricular (LV) function with enhanced O2− production in the heart, which was accompanied by increased apoptosis and fibrosis at 13 to 14 months of age. On the other hand, the level of oxidative stress was attenuated in Tg-Nox4-P437H. Although the size of cardiac myocytes was significantly greater in Tg-Nox4 than in nontransgenic, the LV weight/tibial length was not significantly altered in Tg-Nox4 mice. Overexpression of Nox4 in cultured cardiac myocytes induced apoptotic cell death but not hypertrophy. Nox4 is primarily localized in mitochondria and upregulation of Nox4 enhanced both rotenone- and diphenyleneiodonium-sensitive O2− production in mitochondria. Cysteine residues in mitochondrial proteins, including aconitase and NADH dehydrogenases, were oxidized and their activities decreased in Tg-Nox4. Conclusions: Upregulation of Nox4 by hypertrophic stimuli and aging induces oxidative stress, apoptosis and LV dysfunction, in part because of mitochondrial insufficiency caused by increased O2− production and consequent cysteine oxidation in mitochondrial proteins.

[1]  Dan Shao,et al.  Nicotinamide Phosphoribosyltransferase Regulates Cell Survival Through NAD+ Synthesis in Cardiac Myocytes , 2009, Circulation research.

[2]  H. Abboud,et al.  Subcellular localization of Nox4 and regulation in diabetes , 2009, Proceedings of the National Academy of Sciences.

[3]  H. Tsutsui,et al.  Mitochondrial oxidative stress and dysfunction in myocardial remodelling. , 2008, Cardiovascular research.

[4]  J. Sadoshima,et al.  Quantitative analysis of redox-sensitive proteome with DIGE and ICAT. , 2008, Journal of proteome research.

[5]  H. Sumimoto Structure, regulation and evolution of Nox‐family NADPH oxidases that produce reactive oxygen species , 2008, The FEBS journal.

[6]  K. Krause,et al.  NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. , 2007, The Biochemical journal.

[7]  W. Seeger,et al.  Hypoxia-Dependent Regulation of Nonphagocytic NADPH Oxidase Subunit NOX4 in the Pulmonary Vasculature , 2007, Circulation research.

[8]  T. Kawahara,et al.  Regulation of Nox and Duox enzymatic activity and expression. , 2007, Free radical biology & medicine.

[9]  Karl-Heinz Krause,et al.  Aging: A revisited theory based on free radicals generated by NOX family NADPH oxidases , 2007, Experimental Gerontology.

[10]  B. Tian,et al.  Thioredoxin1 upregulates mitochondrial proteins related to oxidative phosphorylation and TCA cycle in the heart. , 2006, Antioxidants & redox signaling.

[11]  J. Sadoshima,et al.  An Angiotensin II Type 1 Receptor Mutant Lacking Epidermal Growth Factor Receptor Transactivation Does Not Induce Angiotensin II–Mediated Cardiac Hypertrophy , 2006, Circulation research.

[12]  Min Zhang,et al.  NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. , 2006, Cardiovascular research.

[13]  Mark A Sussman,et al.  The Rac and Rho Hall of Fame: A Decade of Hypertrophic Signaling Hits , 2006, Circulation research.

[14]  K. Nakagawa,et al.  The superoxide‐producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells , 2005, Genes to cells : devoted to molecular & cellular mechanisms.

[15]  H. Abboud,et al.  Nox4 NAD(P)H Oxidase Mediates Hypertrophy and Fibronectin Expression in the Diabetic Kidney* , 2005, Journal of Biological Chemistry.

[16]  D. Sorescu,et al.  NAD(P)H Oxidase 4 Mediates Transforming Growth Factor-β1–Induced Differentiation of Cardiac Fibroblasts Into Myofibroblasts , 2005, Circulation research.

[17]  H. Kikuchi,et al.  The NADPH Oxidase Nox3 Constitutively Produces Superoxide in a p22phox-dependent Manner , 2005, Journal of Biological Chemistry.

[18]  M. Ikeda-Saito,et al.  Reversible redox-dependent modulation of mitochondrial aconitase and proteolytic activity during in vivo cardiac ischemia/reperfusion , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Robert S. Balaban,et al.  Mitochondria, Oxidants, and Aging , 2005, Cell.

[20]  M. Geiszt,et al.  The Nox Family of NAD(P)H Oxidases: Host Defense and Beyond* , 2004, Journal of Biological Chemistry.

[21]  Pravir Kumar,et al.  Direct Interaction of the Novel Nox Proteins with p22phox Is Required for the Formation of a Functionally Active NADPH Oxidase* , 2004, Journal of Biological Chemistry.

[22]  K. Griendling,et al.  Distinct Subcellular Localizations of Nox1 and Nox4 in Vascular Smooth Muscle Cells , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[23]  Masahiro Ito,et al.  Pressure Overload–Induced Myocardial Hypertrophy in Mice Does Not Require gp91phox , 2004, Circulation.

[24]  H. Motoshima,et al.  The NAD(P)H Oxidase Homolog Nox4 Modulates Insulin-Stimulated Generation of H2O2 and Plays an Integral Role in Insulin Signal Transduction , 2004, Molecular and Cellular Biology.

[25]  S. Ibayashi,et al.  Nox4 as the Major Catalytic Component of an Endothelial NAD(P)H Oxidase , 2004, Circulation.

[26]  A. Shah,et al.  Contrasting Roles of NADPH Oxidase Isoforms in Pressure-Overload Versus Angiotensin II–Induced Cardiac Hypertrophy , 2003, Circulation research.

[27]  H. Abboud,et al.  Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. , 2003, American journal of physiology. Renal physiology.

[28]  S. Vatner,et al.  Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. , 2003, The Journal of clinical investigation.

[29]  D. Sorescu,et al.  Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. , 2002, Congestive heart failure.

[30]  A. Shah,et al.  Pivotal Role of a gp91phox-Containing NADPH Oxidase in Angiotensin II-Induced Cardiac Hypertrophy in Mice , 2002, Circulation.

[31]  S. Vatner,et al.  Chelerythrine rapidly induces apoptosis through generation of reactive oxygen species in cardiac myocytes. , 2001, Journal of molecular and cellular cardiology.

[32]  D. Kang,et al.  Mitochondrial DNA Damage and Dysfunction Associated With Oxidative Stress in Failing Hearts After Myocardial Infarction , 2001, Circulation research.

[33]  M. Hattori,et al.  A Novel Superoxide-producing NAD(P)H Oxidase in Kidney* , 2001, The Journal of Biological Chemistry.

[34]  Steven J. Sollott,et al.  Reactive Oxygen Species (Ros-Induced) Ros Release , 2000, The Journal of experimental medicine.

[35]  G. Condorelli,et al.  The Akt-Glycogen Synthase Kinase 3β Pathway Regulates Transcription of Atrial Natriuretic Factor Induced by β-Adrenergic Receptor Stimulation in Cardiac Myocytes* , 2000, The Journal of Biological Chemistry.

[36]  A. Takeshita,et al.  Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. , 1999, Circulation research.

[37]  L. Ji,et al.  Myocardial aging: antioxidant enzyme systems and related biochemical properties. , 1991, The American journal of physiology.

[38]  K. Krause,et al.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.

[39]  M. Dinauer,et al.  Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. , 2006, Cellular signalling.